Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Existential Distress in Advanced Cancer: Pragmatic Randomized Controlled Trial of a Short-term Psychodynamic Psychotherapy (ORPHYS) Compared to Treatment as Usual (TAU)

NCT07312760 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT07312760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Existential Distress in Advanced Cancer: Pragmatic Randomized Controlled Trial of a Short-term Psychodynamic Psychotherapy (ORPHYS) Compared to Treatment as Usual (TAU)
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Not applicable
Overall status
Recruiting
Start date
October 24, 2025
Completion date
December 31, 2027
Enrollment
160 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, various, nos